Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Notes Payables (2016 - 2020)

Dare Bioscience's Notes Payables history spans 4 years, with the latest figure at $367285.0 for Q4 2020.

  • For Q4 2020, Notes Payables changed N/A year-over-year to $367285.0; the TTM value through Dec 2020 reached $367285.0, changed N/A, while the annual FY2020 figure was $367285.0, N/A changed from the prior year.
  • Notes Payables reached $367285.0 in Q4 2020 per DARE's latest filing, roughly flat from $367285.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $697500.0 in Q4 2016 to a low of $367285.0 in Q2 2020.